4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Deep Track Capital, LP's stake in 4d Molecular Therapeutics, Inc. fell to 1.32% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Deep Track Capital, LP's stake in 4d Molecular Therapeutics, Inc. fell to 1.32%, 609,900 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 1.32%
- Shares
- 609,900
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 1.32% | 609,900 |
| Deep Track Biotechnology Master Fund, Ltd. | 1.32% | 609,900 |
| David Kroin | 1.32% | 609,900 |